CTXR Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss CDLR Q1 2026 Earnings EPS Misses Estimates as Operating Costs Weigh on Results C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution Brandywine Realty Trust Q1 2026 Earnings Narrow FFO Miss as Office Market Pressure Persists Afya Limited Q1 2026 Earnings EPS Misses Estimates Amid Steady Operations Park Aerospace Corp Q1 2026 Earnings EPS of 015 Exceeds Prior Year Performance Stock Rises 488